Guillaume Passot

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis

Pierre‐Emmanuel Bonnot, Guillaume Piessen, Vahan Képénékian et al. · Journal of Clinical Oncology · 2019 · 387 citations

RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases

Kristoffer W. Brudvik, Robert Jones, Felice Giuliante et al. · Annals of Surgery · 2017 · 266 citations

GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study

Olivier Gléhen, Guillaume Passot, Laurent Villeneuve et al. · BMC Cancer · 2014 · 212 citations · Full text

Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases

Yun Shin Chun, Guillaume Passot, Suguru Yamashita et al. · Annals of Surgery · 2017 · 163 citations · Full text

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery

Arancha Prada-Villaverde, Jesús Esquivel, Andrew M. Lowy et al. · Journal of Surgical Oncology · 2014 · 160 citations